Plain-English translation of NCT05977998 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , a chemotherapy drug, given directly into the abdomen to treat advanced stomach cancer that has spread to the lining of the belly. You would receive the medication for 6 weeks, possibly have surgery to remove your stomach, and then receive more of the medication for another 6 weeks. Researchers want to see if this approach helps people live longer and can be done safely.
Advanced stomach cancer that spreads to the abdominal lining is very difficult to treat and currently has few good options. This trial is exploring whether giving this medication directly into the abdomen—combined with surgery—might be more effective than current standard treatments.
You likely qualify if…
You likely don't qualify if…
You will receive the chemotherapy medication once every 2 weeks for 6 weeks at the hospital or clinic. After that, your doctor will decide whether surgery to remove your stomach is appropriate for you. If surgery happens, you will recover and then return for another 6 weeks of the same medication schedule. Throughout the trial, you will have regular blood tests and visits to monitor how you are responding and to check for side effects.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States